|
2024 Journal Article Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSDSiriratnam, Pakeeran, Huda, Saif, Van Der Walt, Anneke, Sanfilippo, Paul G., Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Z., Zhu, Chao, Khoury, Samia J., Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Ramo-Tello, Cristina M., Laureys, Guy, Patti, Francesco, Horakova, Dana, Foschi, Matteo, Boz, Cavit, McCombe, Pamela A., Turkoglu, Recai, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Jokubaitis, Vilija G., Butzkueven, Helmut ... for MSBase (2024). Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSD. Neurology, 103 (12) e209940, 1-8. doi: 10.1212/wnl.0000000000209940 |
|
2024 Journal Article Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry studyKreiter, Daniel, Kalincik, Tomas, Hupperts, Raymond, Patti, Francesco, Spitaleri, Daniele, Foschi, Matteo, Surcinelli, Andrea, Maimone, Davide, Yamout, Bassem, Khoury, Samia J., Lechner-Scott, Jeannette, Ozakbas, Serkan, Gerlach, Oliver, Turkoglu, R., Soysal, A., Boz, C., Al-Asmi, A., Alkhaboori, J., Amato, M. P., Onofrj, M., Lugaresi, A., Besora, S., Sanchez-Menoyo, J. L., Lapointe, E., Grand’Maison, F., Grammond, P., Butzkueven, H., Van der Walt, A., Taylor, B. V. ... Barnett, M. H. (2024). Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry study. CNS Drugs, 38 (11), 921-930. doi: 10.1007/s40263-024-01115-x |
|
2024 Conference Publication DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosisMaltby, Vicki E., Xavier, Alexandre, Monif, Mastura, Min, Myintzu, Fabis-Pedrini, Marzena J., Buzzard, Katherine, Kalincik, Tomas, Kermode, Allan G., Taylor, Bruce, Hodgkinson, Suzanne, McCombe, Pamela, Osborne, Meaghan, Butzkueven, Helmut, Barnett, Michael, Lea, Rodney A. and Lechner-Scott, Jeannette (2024). DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapiesYeh, Wei Z., Van Der Walt, Anneke, Skibina, Olga G., Kalincik, Tomas, Alroughani, Raed, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Lechner-Scott, Jeannette, Boz, Cavit, Ozakbas, Serkan, Buzzard, Katherine, Habek, Mario, John, Nevin A., Prat, Alexandre, Girard, Marc, Duquette, Pierre, Baghbanian, Seyed Mohammad, Hodgkinson, Suzanne, Van Pesch, Vincent, Laureys, Guy, Willekens, Barbara, Prevost, Julie, Foschi, Matteo, De Gans, Koen, Horakova, Dana, Havrdova, Eva Kubala, Karabudak, Rana, Patti, Francesco ... for the MSBase Study Group (2024). Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies. Neurology Neuroimmunology and Neuroinflammation, 11 (6) e200328, 1-16. doi: 10.1212/nxi.0000000000200328 |
|
2024 Conference Publication The risk of secondary progressive multiple sclerosis is geographically determined but modifiableSharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Kermode, Allan, Butler, Ernest, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Taylor, Bruce, Slee, Mark, Macdonell, Richard, Garber, Justin, Shaw, Cameron, Shuey, Neil, Massey, Jennifer, Hardy, Todd, Parratt, John and Kalincik, Tomas (2024). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Assessing the effect of Riluzole on motor unit discharge propertiesShandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053 |
|
2024 Journal Article Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymesTupil, Ajay R., Rivlin, Warwick, Mccombe, Pamela A., Henderson, Robert D., Rodgers, Jonathan and Vadlamudi, Lata (2024). Diagnosing late-onset Tay-Sachs through next generation sequencing and functional enzyme testing: from genes to enzymes. Neurology Genetics, 10 (6) e200205, e200205. doi: 10.1212/nxg.0000000000200205 |
|
2024 Conference Publication Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaborationLaing, N., Kennerson, M., Lamont, P., Vucic, S., Davis, M., Bryson-Richardson, R., Ravenscroft, G., Perez-Siles, G., Ghaoui, R., Narayanan, R., McCombe, P., Deveson, I., Bryen, S., Grosz, B., Johari, M., Rick, A., Folland, C., Scriba, C., Parmar, J. and Ellis, M. (2024). Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration. 29th International Congress of the World-Muscle-Society (WMS), Prague, Czech Republic, 8-12 October 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.nmd.2024.07.328 |
|
2024 Journal Article Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studySiriratnam, Pakeeran, Sanfilippo, Paul, van der Walt, Anneke, Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Zhen, Zhu, Chao, Khoury, Samia Joseph, Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas,, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Yamout, Bassem, Laureys, Guy, Patti, Francesco, Simo, Magdolna, Surcinelli, Andrea, Foschi, Matteo, McCombe, Pamela A, Alroughani, Raed, Sánchez-Menoyo, José Luis, Turkoglu, Recai, Soysal, Aysun, Lechner Scott, Jeanette, Kalincik, Tomas, Butzkueven, Helmut ... Monif, Mastura (2024). Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study. Journal of Neurology, Neurosurgery and Psychiatry, 96 (4) jnnp-2024-334090, 1-9. doi: 10.1136/jnnp-2024-334090 |
|
2024 Conference Publication Real-world experience with Cladribine (Mavenclad) in the MSBase registryButzkueven, Helmut, Spelman, Tim, Van der Walt, Anneke, Hodgkinson, Suzanne, Ozakbas, Serkan, Alroughani, Raed, Kalincik, Tomas, Eichau, Sara, Boz, Cavit, Buzzard, Katherine, Habek, Mario, John, Nevin, Kermode, Allan G., Foschi, Matteo, McCombe, Pamela, Gerlach, Oliver, Prevost, Julie, Meca-Lallana, Jose E., Lapointe, Emmanuelle and Jarvinen, Elina (2024). Real-world experience with Cladribine (Mavenclad) in the MSBase registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase RegistryBarnett, Michael, van der Walt, Anneke, Butzkueven, Helmut, Kalincik, Tomas, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Hodgkinson, Suzanne, McCombe, Pamela, Macdonell, Richard, Slee, Mark, Migocki, Margaret, Martel, Kate and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase Registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosisRoos, Izanne, Sharmin, Sifat, Malpas, Charles, Ozakbas, Serkan, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Alroughani, Raed, Eichau Madueño, Sara, Boz, Cavit, van der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Grand’Maison, Francois, John, Nevin, Grammond, Pierre, Terzi, Murat, Prévost, Julie, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Luis Sanchez-Menoyo, Jose, Blanco, Yolanda, Oh, Jiwon, McCombe, Pamela, Ramo Tello, Cristina, Soysal, Aysun, Prat, Alexandre ... Kalincik, Tomas (2024). Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 30 (9), 1163-1175. doi: 10.1177/13524585241267211 |
|
2024 Conference Publication Utilisation of high efficacy therapy for managing multiple sclerosis in AustraliaMcCombe, Pamela, Butzkueven, Helmut, Samjoo, Imtiaz, Barnett, Michael, Broadley, Simon, Walt, Anneke Van der, Merschhemke, Martin, Adlard, Nicholas, Burke, Naomi, Riley, Nicholas and Walker, Rob (2024). Utilisation of high efficacy therapy for managing multiple sclerosis in Australia. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.23 |
|
2024 Conference Publication Real-world Australian experience with Ofatumumab in the MSBase registryMigocki, Margaret, Walt, Anneke Van der, Butzkueven, Helmut, Spelman, Tim, Kermode, Allan, Fabis-Pedrini, Marzena, Carroll, William M., Lechner-Scott, Jeannette, John, Nevin, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark and Schmitt, Birte (2024). Real-world Australian experience with Ofatumumab in the MSBase registry. ANZAN Annual Scientific Meeting 2024, Adelaide, SA Australia, 21-24 May 2024. London, United Kingdom: BMJ Group. doi: 10.1136/bmjno-2024-anzan.127 |
|
2024 Journal Article Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patientsJiang, Leanne, Tracey, Timothy J., Gill, Melinder K., Howe, Stephanie L., Power, Dominique T., Bharti, Vanda, McCombe, Pamela A., Henderson, Robert D., Steyn, Frederik J. and Ngo, Shyuan T. (2024). Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients. Stem Cell Research, 78 103447, 1-6. doi: 10.1016/j.scr.2024.103447 |
|
2024 Conference Publication Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple SclerosisNelson, Morag, Butzkueven, Helmut, Van der Walt, Anneke, Broadley, Simon, Riley, Nicholas, Adlard, Nicholas, Merschhemke, Martin, Stoneman, Dee, McCombe, Pamela, Barnett, Michael, Walker, Rob, Samjoo, Imtiaz, Haltner, Anja and Drudge, Chris (2024). Employing Novel Indirect Treatment Comparison Methodologies to Differentiate the Efficacy of Ofatumumab and Other High Efficacy Therapies versus Orally Administered Disease Modifying Therapies for Relapsing Multiple Sclerosis. 16th Congress of the Pan-Asian Committee for Treatment and Research in Multiple Sclerosis, Bangkok, Thailand, 30 October - 2 November 2024. London, United Kingdom: Sage Publications. |
|
2024 Journal Article The clinical relevance of MOG antibody testing in cerebrospinal fluidReynolds, Molly, Tan, Irene, Nguyen, Kristy, Merheb, Vera, Lee, Fiona X. Z., Trewin, Benjamin P, Lerch, Magdalena, Shah, Snehal, Wolfe, Nigel, Buzzard, Katherine, Lechner-Scott, Jeannette, Fabis-Pedrini, Marzena, Fok, Anthony, John, Nevin, Kneebone, Chris, Yiannikas, Con, Brown, David A., Kermode, Allan G., Reddel, Stephen, Dale, Russell C., Brilot, Fabienne, Ramanathan, Sudarshini, Adam, Robert, Andersen, Jane, Andrews, Ian, Antony, Jayne, Aouad, Patrick, Badve, Monica, Barnett, Michael H. ... on behalf of the Australasian MOGAD Study Group (2024). The clinical relevance of MOG antibody testing in cerebrospinal fluid. Annals of Clinical and Translational Neurology, 11 (9), 1-6. doi: 10.1002/acn3.52163 |
|
2024 Journal Article General neurology: Current challenges and future implicationsBassetti, Claudio Lino Alberto, Accorroni, Alice, Arnesen, Astri, Basri, Hamidon Bin, Berger, Thomas, Berlit, Peter, Boon, Paul, Charway-Felli, Augustina, Kruja, Jera, Lewis, Steven, Markowski, Michael, Medina, Marco Tulio, McComb, Pamela, Moro, Elena, Ozturk, Serefnur, Smith, Paul and Vuletic, Vladimira (2024). General neurology: Current challenges and future implications. European Journal of Neurology, 31 (6) e16237, 1-11. doi: 10.1111/ene.16237 |
|
2024 Journal Article A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemicLal, Anoushka P., Foong, Yi Chao, Sanfilippo, Paul G., Spelman, Tim, Rath, Louise, Levitz, David, Fabis-Pedrini, Marzena, Foschi, Matteo, Habek, Mario, Kalincik, Tomas, Roos, Izanne, Lechner-Scott, Jeannette, John, Nevin, Soysal, Aysun, D’Amico, Emanuele, Gouider, Riadh, Mrabet, Saloua, Gross-Paju, Katrin, Cárdenas-Robledo, Simón, Moghadasi, Abdorreza Naser, Sa, Maria Jose, Gray, Orla, Oh, Jiwon, Reddel, Stephen, Ramanathan, Sudarshini, Al-Harbi, Talal, Altintas, Ayse, Hardy, Todd A., Ozakbas, Serkan ... Van der Walt, Anneke (2024). A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic. Journal of Neurology, 271 (9), 5813-5824. doi: 10.1007/s00415-024-12518-7 |
|
2024 Journal Article Verbal and nonverbal fluency in amyotrophic lateral sclerosisBarker, Megan S., Ceslis, Amelia, Argall, Rosemary, McCombe, Pamela, Henderson, Robert D. and Robinson, Gail A. (2024). Verbal and nonverbal fluency in amyotrophic lateral sclerosis. Journal of Neuropsychology, 18 (2), 265-285. doi: 10.1111/jnp.12354 |
